BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taïeb D, Jha A, Treglia G, Pacak K. Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups. Endocr Relat Cancer 2019;26:R627-52. [PMID: 31561209 DOI: 10.1530/ERC-19-0165] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Lussey-Lepoutre C, Bellucci A, Burnichon N, Amar L, Buffet A, Drossart T, Fontaine S, Clement O, Benit P, Rustin P, Groussin L, Meatchi T, Gimenez-Roqueplo AP, Tavitian B, Favier J. Succinate detection using in vivo 1H-MR spectroscopy identifies germline and somatic SDHx mutations in paragangliomas. Eur J Nucl Med Mol Imaging 2020;47:1510-7. [PMID: 31834447 DOI: 10.1007/s00259-019-04633-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
2 Wang K, Tang G, Peng Y, Li C, Fu W, Li R, Guan J. Adrenal pheochromocytoma: is it all or the tip of the iceberg? Jpn J Radiol 2021. [PMID: 34546504 DOI: 10.1007/s11604-021-01199-1] [Reference Citation Analysis]
3 Weiss NM. Rare Diseases of the Middle Ear and Lateral Skull Base. Laryngorhinootologie 2021;100:S1-S30. [PMID: 34352901 DOI: 10.1055/a-1347-4171] [Reference Citation Analysis]
4 Treglia G, Sadeghi R, Giovinazzo F, Galiandro F, Annunziata S, Muoio B, Kroiss AS. PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses. Cancers (Basel) 2021;13:5172. [PMID: 34680321 DOI: 10.3390/cancers13205172] [Reference Citation Analysis]
5 Gubbi S, Al-Jundi M, Del Rivero J, Jha A, Knue M, Zou J, Turkbey B, Carrasquillo JA, Lin E, Pacak K, Klubo-Gwiezdzinska J, Lin FI. Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma. Front Endocrinol (Lausanne) 2020;11:587065. [PMID: 33551992 DOI: 10.3389/fendo.2020.587065] [Reference Citation Analysis]
6 Amar L, Pacak K, Steichen O, Akker SA, Aylwin SJB, Baudin E, Buffet A, Burnichon N, Clifton-Bligh RJ, Dahia PLM, Fassnacht M, Grossman AB, Herman P, Hicks RJ, Januszewicz A, Jimenez C, Kunst HPM, Lewis D, Mannelli M, Naruse M, Robledo M, Taïeb D, Taylor DR, Timmers HJLM, Treglia G, Tufton N, Young WF, Lenders JWM, Gimenez-Roqueplo AP, Lussey-Lepoutre C. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nat Rev Endocrinol 2021;17:435-44. [PMID: 34021277 DOI: 10.1038/s41574-021-00492-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 20.0] [Reference Citation Analysis]
7 Tepede AA, Welch J, Lee M, Mandl A, Agarwal SK, Nilubol N, Patel D, Cochran C, Simonds WF, Weinstein LS, Jha A, Millo C, Pacak K, Blau JE. 18F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma. Endocrinol Diabetes Metab Case Rep 2020;2020:EDM190156. [PMID: 32130200 DOI: 10.1530/EDM-19-0156] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Calissendorff J, Juhlin CC, Bancos I, Falhammar H. Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance. Cancers 2022;14:917. [DOI: 10.3390/cancers14040917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Treglia G, Raditchkova M, Giovanella L, Stelmes JJ, Bosetti DG, Martucci F. Two Birds with One Stone: Skull Base Meningioma and Jugulotympanic Paragangliomas with Somatostatin Receptor Positron Emission Tomography. Diagnostics (Basel) 2021;11:1669. [PMID: 34574010 DOI: 10.3390/diagnostics11091669] [Reference Citation Analysis]
10 Tella SH, Jha A, Taïeb D, Horvath KA, Pacak K. Comprehensive review of evaluation and management of cardiac paragangliomas. Heart 2020;106:1202-10. [PMID: 32444502 DOI: 10.1136/heartjnl-2020-316540] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Okamoto S, Shiga T, Tamaki N. Clinical Perspectives of Theranostics. Molecules 2021;26:2232. [PMID: 33924345 DOI: 10.3390/molecules26082232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Patel M, Tena I, Jha A, Taieb D, Pacak K. Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World. Front Endocrinol (Lausanne) 2021;12:625312. [PMID: 33854479 DOI: 10.3389/fendo.2021.625312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Iravani A, Parihar AS, Akhurst T, Hicks RJ. Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms. Cancer Imaging 2022;22. [DOI: 10.1186/s40644-022-00465-3] [Reference Citation Analysis]
14 Królicki L, Kunikowska J. Theranostics – present and future. Bio-Algorithms and Med-Systems 2022;17:213-20. [DOI: 10.1515/bams-2021-0169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 O'neill E, Cornelissen B. Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy. Nuclear Medicine and Biology 2022. [DOI: 10.1016/j.nucmedbio.2022.02.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Stojanoski S, Boldt HB, Kozic D, Patócs A, Korbonits M, Medic-Stojanoska M, Casar-Borota O. Case Report: Malignant Primary Sellar Paraganglioma With Unusual Genetic and Imaging Features. Front Oncol 2021;11:739255. [PMID: 34888235 DOI: 10.3389/fonc.2021.739255] [Reference Citation Analysis]
17 Nunes RF, Zuppani RMF, Coutinho AM, Barbosa FG, Sapienza MT, Marin JFG, Buchpiguel CA. General Concepts in Theranostics. PET Clin 2021;16:313-26. [PMID: 34053576 DOI: 10.1016/j.cpet.2021.03.010] [Reference Citation Analysis]
18 Kuhlen M, Pamporaki C, Kunstreich M, Wudy SA, Hartmann MF, Peitzsch M, Vokuhl C, Seitz G, Kreissl MC, Simon T, Hero B, Frühwald MC, Vorwerk P, Redlich A. Adrenocortical Tumors and Pheochromocytoma/Paraganglioma Initially Mistaken as Neuroblastoma—Experiences From the GPOH-MET Registry. Front Endocrinol 2022;13:918435. [DOI: 10.3389/fendo.2022.918435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kuo MJM, Nazari MA, Jha A, Pacak K. Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches. Front Endocrinol 2022;13:936178. [DOI: 10.3389/fendo.2022.936178] [Reference Citation Analysis]
20 Mohr H, Foscarini A, Steiger K, Ballke S, Rischpler C, Schilling F, Pellegata NS. Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment. EJNMMI Res 2021;11:121. [PMID: 34894301 DOI: 10.1186/s13550-021-00855-x] [Reference Citation Analysis]
21 Sarkadi B, Saskoi E, Butz H, Patocs A. Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach. Int J Mol Sci 2022;23:1450. [PMID: 35163370 DOI: 10.3390/ijms23031450] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Jha A, Taïeb D, Carrasquillo JA, Pryma DA, Patel M, Millo C, de Herder WW, Del Rivero J, Crona J, Shulkin BL, Virgolini I, Chen AP, Mittal BR, Basu S, Dillon JS, Hope TA, Mari Aparici C, Iagaru AH, Hicks RJ, Avram AM, Strosberg JR, Civelek AC, Lin FI, Pandit-Taskar N, Pacak K. High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma. Clin Cancer Res 2021;27:2989-95. [PMID: 33685867 DOI: 10.1158/1078-0432.CCR-20-3703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
23 Huang W, Gao G, Chen Z, Qiu Y, Gao J, Kang L. Multimodality Imaging Evaluation of Primary Right Atrial Paraganglioma: A Case Report and Literature Review. Front Med 2022;9:942558. [DOI: 10.3389/fmed.2022.942558] [Reference Citation Analysis]
24 Ilanchezhian M, Jha A, Pacak K, Del Rivero J. Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma. Curr Treat Options Oncol 2020;21:85. [PMID: 32862332 DOI: 10.1007/s11864-020-00787-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
25 Talvacchio S, Nazari MA, Pacak K. Supportive management of patients with pheochromocytoma/paraganglioma undergoing noninvasive treatment. Curr Opin Endocrinol Diabetes Obes 2022;29:294-301. [PMID: 35621181 DOI: 10.1097/MED.0000000000000724] [Reference Citation Analysis]
26 Jha A, Patel M, Baker E, Gonzales MK, Ling A, Millo C, Knue M, Civelek AC, Pacak K. Role of 68Ga-DOTATATE PET/CT in a Case of SDHB-Related Pterygopalatine Fossa Paraganglioma Successfully Controlled with Octreotide. Nucl Med Mol Imaging 2020;54:48-52. [PMID: 32206131 DOI: 10.1007/s13139-019-00629-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Dahia PLM, Clifton-Bligh R, Gimenez-Roqueplo AP, Robledo M, Jimenez C. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshop. Endocr Relat Cancer 2020;27:T41-52. [PMID: 32069214 DOI: 10.1530/ERC-19-0435] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
28 Patel M, Jha A, Antic T, Nielsen SM, Churpek JE, Ling A, Pacak K. 68Ga-DOTATATE Avid Metastatic Vertebral Renal Cell Carcinoma in the Setting of von Hippel-Lindau Syndrome. Nucl Med Mol Imaging. [DOI: 10.1007/s13139-022-00761-7] [Reference Citation Analysis]